Details of the Drug Formulaction

General Information of Drug Formulation (ID: F24258)

• Formulation Name: Crisaborole 2% ointment
• Company: Pfizer Laboratories Div Pfizer ; PharmaciaUpjohn

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
crisaborole	(DMNVKU6)	Atopic dermatitis	EA80	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Butylated hydroxytoluene	(E00336)	31404	Antioxidant
Edetate calcium disodium	(E00487)	6093170	Complexing agent
Glyceryl monostearate	(E00310)	24699	Emollient; Emulsifying agent; Emulsion stabilizing agent; Solubilizing agent; Surfactant; Viscosity-controlling agent
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent